These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Levamisole as an immunotherapeutic agent in the treatment of cancer. Amery WK World J Surg; 1977 Sep; 1(5):597-604. PubMed ID: 272084 [No Abstract] [Full Text] [Related]
8. [Effect of levamisole on the cellular immunity indices of patients with active forms of brucellosis]. Mukovozova LA Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):61-5. PubMed ID: 3262973 [TBL] [Abstract][Full Text] [Related]
9. Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer. Stevenson HC; Green I; Hamilton JM; Calabro BA; Parkinson DR J Clin Oncol; 1991 Nov; 9(11):2052-66. PubMed ID: 1941064 [TBL] [Abstract][Full Text] [Related]
10. [Effect of levamisole on the cellular and humoral immunity indices in patients with chronic brucellosis]. Mukovozova LA Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):45-9. PubMed ID: 3265248 [TBL] [Abstract][Full Text] [Related]
11. [Dynamics of the humoral immunity indices in patients with subacute brucellosis being treated with levamisole]. Mukovozova LA Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):56-9. PubMed ID: 3499730 [TBL] [Abstract][Full Text] [Related]
12. Levamisole in the treatment of chronic brucellosis. Raptopoulou-Gigi M; Kountouras J; Goulis G J Immunopharmacol; 1980; 2(1):85-97. PubMed ID: 7005350 [TBL] [Abstract][Full Text] [Related]
13. Use of levamisole in cancer patients. Spreafico F Drugs; 1980 Aug; 20(2):105-16. PubMed ID: 6995092 [No Abstract] [Full Text] [Related]
14. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems. Johnson RK; Houchens DP; Gaston MR; Goldin A Cancer Chemother Rep; 1975; 59(4):697-705. PubMed ID: 1175164 [TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trials. Carter SK; Selawry O Natl Cancer Inst Monogr; 1977 Mar; (45):81-92. PubMed ID: 337157 [No Abstract] [Full Text] [Related]
16. New agents and combinations in the treatment of bronchogenic carcinoma. Bodey GP; Gottlieb JA; Livingston R; Frei E Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740 [No Abstract] [Full Text] [Related]
17. Reevaluation of the effect of levamisole in chronic brucellosis: in vitro and in vivo effect on monocyte phagocytosis. Boura P; Raptopoulou-Gigi M; Acriviadis E; Goulis G J Immunopharmacol; 1984; 6(3):135-46. PubMed ID: 6333466 [TBL] [Abstract][Full Text] [Related]
18. [Comparative effectiveness of levamisole and vaccine in the complex treatment of patients with brucellosis]. Mukovozova LA Ter Arkh; 1986; 58(10):43-5. PubMed ID: 3541274 [TBL] [Abstract][Full Text] [Related]
19. Levamisole or placebo after effective chemotherapy for remission and survival prolongation in advanced human solid tumors--a double-blind randomized trial. Focan C; Schyns-Mosen J; Focan-Henrard D Acta Oncol; 1989; 28(1):105-6. PubMed ID: 2650718 [No Abstract] [Full Text] [Related]
20. Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data. Amery WK; Spreafico F; Rojas AF; Denissen E; Chirigos M Cancer Treat Rev; 1977 Sep; 4(3):167-94. PubMed ID: 589606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]